Sen. Kennedy Death Puts Focus On Brain Cancer

The recent death of Senator Ted Kennedy has focused new attention on brain cancer.  Glioblastoma multiforme (GBM), the aggressive brain tumor that took Sen. Kennedy’s life, is one of the deadliest brain tumors that can occur in both adults and children.  It is also one of the most difficult tumors to...

The Key to Stopping Colon Cancer?

Scientists in Switzerland may have found a way to inhibit the growth of colon cancer in humans, says a new study published in EMBO Molecular Medicine. Researchers in Geneva discovered that by blocking a particular biological pathway, they could prevent the growth of tumors, metastatic lesions, and cancer...

Another Company Announces Positive Lupus Drug Data

Immunomedics has become the second biopharmaceutical company in recent weeks to announce a successful trial of its lupus drug. The company’s lupus medication, epratuzumab, showed a 24.9% advantage over a placebo in a 12-week Phase IIb clinical trial. Shares in Immunomedics jumped 57 percent to its...

Protalix Granted Fast-Track Review for Gaucher Drug

The U.S. Food and Drug Administration has granted a fast-track review to Protalix BioTherapeutics‘ experimental treatment for Gaucher disease. Fast-track designation allows the agency to review late-stage data as it becomes available, instead of waiting for complete Phase III data to be submitted. The...

NeoPharm Tipped As Stock to Watch

NeoPharm (NEOL.PK), a biopharmaceutical company developing drugs for cancer treatment, has been tipped as a worthwhile stock on financial website Seeking Alpha. The writer cited the stock’s low cost and the company’s impressive cancer-fighting pipeline as reasons to invest. NeoPharm is...

BioNeutral Ygiene Kills Swine Flu in 20 Seconds, Test Shows

BioNeutral of Newark, NJ, announced that its Ygiene Consumer Grade antimicrobial formulation swiftly eradicated the H1N1 swine flu virus in an independent lab test. Researchers at Microbiotest of Sterling, Virginia, found that Ygiene eliminated the swine flu virus within 20 seconds. The findings suggest that...

Power3 Medical Files for 3 Patents for Breast Cancer Test

Power3 Medical Products, a company specializing in disease detection through the analysis of proteins, has filed for three patents on its blood test for the early detection of breast cancer. The Woodlands, TX-based company has identified 22 blood proteins with abnormal concentrations in women with breast...

MediciNova to Buy Avigen for $37 Million

Pharmaceutical company MediciNova (MNOV) announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million. Forbes reports that Avigen had been in talks with MediciNova for over a year. Basic terms of the sale had been agreed upon since June. Avigen, which develops virus-based gene...